Best Supplements to Take With AOD-9604

AOD-9604 Mobilizes Fat, But Burns None of It Alone

AOD-9604 is a 16-amino-acid fragment taken from the tail end of human growth hormone. That origin sounds unremarkable until you understand what was removed. Full-length growth hormone binds a receptor that triggers anabolic growth, raises insulin-like growth factor 1 (IGF-1, a hormone that drives tissue growth and cell proliferation), and at supraphysiologic doses creates insulin resistance. AOD-9604 has none of that. The domains responsible for binding the growth hormone receptor were stripped away deliberately, leaving only the helical region associated with fat mobilization.

What remains targets beta-3 adrenergic receptors, a specific subtype of receptor found predominantly in white adipose tissue and visceral fat. When those receptors are activated, a signaling cascade fires: an enzyme called hormone-sensitive lipase (HSL, the enzyme that breaks down stored fat) gets switched on, triglycerides stored inside fat cells get broken down, and free fatty acids are released into circulation. This is lipolysis, the biochemical process by which the body converts stored fat into a usable fuel. AOD-9604 triggers it directly, at the tissue level, without going through the pituitary gland or raising any systemic growth signal.

This is what makes AOD-9604 categorically different from the GH secretagogues it is frequently grouped with. CJC-1295, Ipamorelin, and MK-677 all work by stimulating the pituitary to release more growth hormone, which then causes downstream effects including fat mobilization, muscle growth, and IGF-1 elevation. AOD-9604 bypasses all of that. It goes directly to the fat cell. No IGF-1 rise. No insulin dysregulation. In six randomized controlled trials involving over 900 participants, its adverse event rate was statistically indistinguishable from placebo.

That clinical cleanliness is genuinely unusual for a compound in this space, but it creates a specific gap for the supplement question. GH secretagogues bring their own systemic effects, many of which have measurable nutritional consequences. AOD-9604 leaves those consequences behind and replaces them with a simpler and sharper one: it is a pure lipolytic with no anabolic arm. When you mobilize fat without a corresponding signal to preserve muscle, and do it daily while in a caloric deficit, lean mass becomes the thing most at risk. The supplements that matter here are the ones that close that gap, plus the cofactors and metabolic infrastructure that determine whether the fatty acids AOD-9604 releases actually get burned rather than just circulating.

One more fact worth understanding before the stack: AOD-9604 is dosed daily and fasted. Insulin, which rises after eating, suppresses the very enzyme AOD-9604 activates. A post-meal insulin rise blunts the lipolytic cascade before it can run. This means the timing of both the peptide and the supplements around it matters, and a few of them need to be positioned specifically to avoid interfering with the fasted injection window.

The Supplements That Support AOD-9604

There are no dose numbers on this page. The right amount of each of these depends on your specific AOD-9604 protocol, your bloodwork, your training volume, and what else you are already taking. MyPeptidePal works that out from your actual situation rather than a generic average.

What the Mitochondria Need to Burn What AOD-9604 Releases

AOD-9604 releases fatty acids from fat cells. That is its job, and in six trials it does it without measurably disrupting anything else. But releasing a fatty acid is only half the equation. For that fatty acid to become energy, it has to travel from the bloodstream into the mitochondria, the compartments inside cells that generate ATP, and be processed through a multi-step oxidation sequence. Two specific molecules are required for that chain to run at full capacity.

L-Carnitine

The mitochondria are surrounded by a double membrane, and long-chain fatty acids cannot cross it on their own. L-carnitine is the shuttle molecule that escorts them through. Without it, free fatty acids accumulate in the bloodstream and cytoplasm rather than being oxidized for energy.

AOD-9604 drives an elevated rate of fatty acid mobilization compared to baseline. That elevated rate creates a larger demand on the carnitine transport system. The body synthesizes some L-carnitine from the amino acids lysine and methionine, but synthesis also depends on adequate vitamin C and iron. There is a meaningful proportion of the population whose carnitine status is genuinely marginal, particularly those eating lower amounts of red meat, which is the primary dietary source, or following plant-based diets where carnitine intake can be close to zero.

The research on L-carnitine supplementation is mixed. Studies in healthy adults with good dietary carnitine show modest effects; studies in deficient populations and older adults show more consistent ones. The mechanism is well-established, and the rationale here is specific to AOD-9604's lipolytic mechanism rather than a generic claim. It earns its slot as a cofactor for the step that follows the peptide's action.

CoQ10

Inside the mitochondria, the fatty acids that carnitine delivers get broken down step by step, and the energy extracted from each step is captured through a series of protein complexes called the electron transport chain. CoQ10, also known as coenzyme Q10, sits at the heart of that chain, shuttling electrons between the complexes. Without it, the chain stalls.

When AOD-9604 is running and fatty acid oxidation is elevated, the mitochondria are processing more substrate than at baseline. A CoQ10 level that was adequate at rest may be less adequate under that increased load. This consideration becomes more concrete for anyone taking a statin medication, because statins cause well-established depletion of CoQ10 by inhibiting the same synthesis pathway that produces cholesterol. Someone on a statin alongside AOD-9604 has a specific and well-supported reason to address this. More broadly, CoQ10 levels decline with age, and since AOD-9604 is often used by older adults seeking body recomposition, baseline depletion is a real possibility rather than a theoretical one.

The evidence for CoQ10 supplementation improving fat oxidation in healthy individuals with adequate levels is not strong. The case here is narrower: cofactor role in mitochondrial function, well-established depletion with statins, and age-related decline. For those not on statins and with no reason to suspect low levels, this is a lower priority than protein and creatine further down the list.

The Deficiencies That Quietly Cap the Result

AOD-9604 is metabolically clean in the sense that it does not cause nutritional shortfalls the way some other compounds do. But it is not running in a vacuum. The person using it is typically in a caloric deficit, exercising regularly, and relying on a metabolic system that has specific nutritional requirements to function at capacity. Three common shortfalls are worth correcting before attributing a suboptimal result to the peptide.

B-Complex

Fatty acid oxidation is not a single reaction. It is a sequence of enzymatic steps, and several of those steps require B vitamins to operate. Vitamin B1 (thiamine) and B2 (riboflavin) are involved in the entry of the acetyl group produced from fatty acids into the energy-production cycle. B3 (niacin) is a core component of NAD, an electron carrier the mitochondria use to capture energy from each oxidation step. B5 (pantothenic acid) is a structural part of coenzyme A, the molecule that carries fatty acids through the oxidation process. B7 (biotin) is required for an enzyme that regenerates a key metabolic intermediate in the cycle.

Deficiencies in these do not announce themselves dramatically. They present as vague fatigue, reduced energy return from exercise, and a blunted response to what should be a working fat-loss protocol. They are common during caloric restriction because B vitamin intake scales with total food intake. A person eating significantly less to support fat loss is frequently eating fewer B vitamins at exactly the time metabolic demand for them is highest.

A complete B-complex taken daily with food fills this gap without requiring separate supplementation of each B vitamin. This is one of the lower-cost, lower-drama entries on the list, and it is frequently the one most overlooked.

Magnesium

Magnesium is a cofactor for a large number of enzymes involved in energy production, including the complex that produces ATP in the mitochondria. It is also required for the enzymes that convert vitamin D from its storage form into the active form that cells can use. Low magnesium means low active vitamin D even in someone who is supplementing vitamin D3, a trap worth avoiding when both nutrients are being addressed.

Magnesium deficiency is widespread. Dietary survey data consistently place intake below recommended levels in a substantial portion of Western adults, and that shortfall is worsened by processed-food diets and by exercise-related sweating. The standard blood test for magnesium, serum magnesium, is a poor indicator of true status because the body regulates serum levels tightly at the expense of tissue stores. Red blood cell magnesium is the more reliable marker and is worth requesting if status is uncertain.

For the AOD-9604 context specifically: the increased mitochondrial activity during elevated fatty acid oxidation places a higher demand on magnesium-dependent enzymatic machinery. This is not a generic argument that magnesium supports health. It is the specific case that the process AOD-9604 initiates depends on infrastructure that magnesium supports, and a common deficiency here quietly limits how much of the lipolytic signal actually converts to burned energy.

Vitamin D3

Vitamin D receptors are expressed in adipocytes, the fat cells that AOD-9604 targets directly. The precise significance of this for a lipolytic peptide protocol has not been tested in a controlled trial, and it would be inaccurate to imply it has been. What is well-supported is the broader context: vitamin D deficiency is extremely common, caloric restriction reduces intake of vitamin D-containing foods, and adequate vitamin D status supports both bone mineral density and general metabolic function during body recomposition.

The bone consideration is specific and worth naming. Someone in a caloric deficit losing body weight is placing altered mechanical load on their skeleton while calcium absorption may be declining. Vitamin D is required for intestinal calcium absorption to function properly. Correcting deficiency here is basic metabolic housekeeping during a protocol that creates conditions where bone is at risk, not a speculative fat-loss strategy.

Magnesium and vitamin D3 address a genuine dependency: magnesium is needed to activate vitamin D, so the two are worth assessing and correcting together rather than in isolation.

Two Pathways to the Same Outcome

AOD-9604 activates the beta-3 adrenergic pathway to drive lipolysis. Two other compounds work along overlapping but distinct biochemical routes toward the same net result: more fat mobilized and oxidized. When stacked alongside AOD-9604, the mechanisms compound rather than duplicate.

Green Tea Extract with Caffeine

When a lipolytic signal fires, it does so partly through norepinephrine, the body's primary fat-mobilization signal. There is an enzyme called catechol-O-methyltransferase (COMT), an enzyme that breaks down norepinephrine, that normally shortens the duration of the lipolytic signal. EGCG, the primary active compound in green tea extract, inhibits COMT. This means the norepinephrine already circulating stays active longer, extending the window in which lipolysis is running.

Caffeine amplifies the same overall process through a different step. It inhibits phosphodiesterase, the enzyme that breaks down cyclic AMP (cAMP, the chemical messenger inside the cell that relays the fat-burning signal). cAMP is the intracellular messenger that translates the beta-3 receptor signal into activation of hormone-sensitive lipase (HSL, the enzyme that breaks down stored fat). By slowing cAMP degradation, caffeine effectively deepens the downstream signaling that AOD-9604 initiates at the receptor level.

The research on green tea extract combined with caffeine as a fat-loss combination is among the better-supported in the supplement literature. Pooled analyses of controlled trials found a modest but consistent reduction in body weight and body fat, with the effect appearing most pronounced in a fasted or calorie-restricted state, which is exactly the context of a daily AOD-9604 protocol.

A practical note for this combination in the stack: both can be taken in the same fasted morning window as AOD-9604. The caution is at the upper end of caffeine intake. Protocol doses combined with high caffeine from other sources create an adrenergic load that can produce elevated heart rate and disrupted sleep. The cautions section covers this in more detail.

Omega-3 Fatty Acids

AOD-9604 sends a continuous stream of fatty acids from adipose tissue into the bloodstream and eventually to the liver. When fat loss is proceeding at a meaningful pace, the liver is processing a larger lipid load than under baseline conditions. Omega-3 fatty acids, specifically EPA and DHA from fish or algae sources, reduce the liver's production of triglyceride-rich lipoprotein particles and support the clearance of excess circulating lipids.

Omega-3s also reduce systemic inflammation, which matters during body recomposition because chronic, low-grade inflammation impairs both fat metabolism and muscle protein synthesis. The evidence for triglyceride reduction from EPA and DHA is among the most robust in the supplement literature, established across numerous controlled trials.

The relationship with AOD-9604 is indirect but concrete: the peptide creates an increased metabolic lipid load, and omega-3s help the body handle that load more cleanly. No direct pharmacological interaction has been identified, and the combination is well tolerated at standard doses.

Protecting the Lean Mass That AOD-9604 Cannot Protect

This is the section most discussions of AOD-9604 miss. The peptide is designed to mobilize fat. It is specifically engineered to do that without any of the growth or anabolic effects of full-length growth hormone. That selectivity is a feature, not a flaw. But it means everything the peptide does not do falls entirely on diet and supplementation.

When the body is in a caloric deficit and fat mobilization is active, muscle protein breakdown competes with fat as a fuel source. The body has no way of knowing whether you want to preserve the muscle. The only signal it has is the combination of dietary protein intake, training stimulus, and intramuscular energy availability. When those are adequate, muscle is preserved. When they fall short, it is not. AOD-9604 cannot send the signal to preserve muscle. Protein and creatine can.

Protein

Muscle protein is in a constant state of being broken down and rebuilt. Net muscle preservation over time requires that rebuilding consistently exceeds breakdown. That rebuilding process, called muscle protein synthesis, is driven by amino acid availability in the bloodstream, particularly leucine and the branched-chain amino acids.

When caloric intake falls during a fat-loss protocol, dietary protein intake tends to fall with it unless specifically defended. When protein intake falls, muscle protein synthesis slows. AOD-9604 does not compensate for this. It does not stimulate muscle protein synthesis, does not activate anabolic pathways, and provides no lean mass protection independent of dietary protein. Research on AOD-9604 confirms explicitly that the compound shows no muscle-preservation activity.

The clinical literature on protein intake during caloric restriction is consistent: higher protein intake produces significantly better lean mass retention than lower intakes at the same caloric deficit. This is a nutritional requirement that supplementation makes easier to meet when food intake is suppressed by a deficit or by appetite changes during a protocol.

Creatine Monohydrate

Protein provides the substrate for muscle. Training provides the signal that muscle needs to be retained. Creatine provides the energy to sustain training quality during a caloric deficit.

Inside muscle cells, creatine is stored as phosphocreatine, a rapidly accessible energy reserve that replenishes ATP between high-intensity efforts. When phosphocreatine stores are well-saturated, training output is better maintained through a session. Higher training output means a stronger and more sustained signal for muscle retention during fat loss. The chain is direct: creatine supports training quality, training quality preserves muscle, and muscle preservation is exactly what AOD-9604 cannot provide on its own.

The muscle-preservation evidence for creatine is well-supported by clinical research across multiple populations, including older adults in caloric restriction, athletes during weight-cutting phases, and patients in catabolic states. It is among the most studied and best-evidenced ergogenic aids in sports nutrition.

One practical note for bloodwork monitoring: creatine supplementation raises serum creatinine, which is a metabolic byproduct of creatine processing in muscle. Creatinine is also the marker used to estimate kidney function. An elevated creatinine in someone taking creatine monohydrate is most likely an artifact of the supplement rather than a sign of kidney stress. Inform any clinician reviewing bloodwork that creatine is being taken, so they do not flag this as a concern when it is not one.

Cautions and Interactions

The Interactions That Directly Block the Mechanism

AOD-9604 activates beta-3 adrenergic receptors on fat cells to initiate lipolysis. Insulin, whether injected or stimulated by medication, suppresses the enzyme this process depends on. This is not a minor interaction. Exogenous insulin and the class of diabetes medications called sulfonylureas and meglitinides directly oppose AOD-9604's mechanism at the cellular level. Someone on any of these medications should not combine AOD-9604 without explicit guidance from their prescriber. The peptide will be working against the medication's effects on glucose management, and the medication will be suppressing the peptide's fat-mobilization mechanism simultaneously.

Non-selective beta-blockers, a class that includes propranolol, block beta receptors throughout the body including the beta-3 subtype. A drug that occupies AOD-9604's target receptor will likely render the peptide ineffective rather than create a dangerous interaction, but the combination undermines the entire rationale for using the compound and should be avoided.

Beta-3 adrenergic agonist medications, such as mirabegron, which is used for overactive bladder, act on the same receptor as AOD-9604. Combining them creates additive stimulation of that receptor, with the potential for unwanted cardiovascular effects including elevated heart rate and blood pressure. This combination should be avoided without medical supervision.

Ephedrine and Ephedra-Containing Products

Avoid ephedrine and ephedra-containing supplements entirely while using AOD-9604. Ephedrine is a sympathomimetic that acts on beta-adrenergic receptors broadly. Combined with AOD-9604's beta-3 receptor activation, the additive adrenergic load creates a meaningful cardiovascular risk, including tachycardia and blood pressure elevation, with no established safety data for the combination. This applies to any product sold as a thermogenic that lists ephedra, ephedrine, or ma huang as an ingredient.

High-Dose Stimulant Stacks

Green tea extract with moderate caffeine is included as a synergist in this stack and is well tolerated at standard amounts. The caution applies at the upper end: combining high-dose caffeine with synephrine or yohimbine creates a combined adrenergic burden that, stacked with AOD-9604's beta-3 activation, can produce heart rate elevation, blood pressure changes, and anxiety in sensitive individuals. If any of those effects appear, reducing the stimulant load is the first adjustment to make.

Biotin at High Doses

Supraphysiologic biotin doses interfere with immunoassay-based hormone tests. The mechanism is specific: high-dose biotin competes with the detection chemistry used in tests for insulin, TSH, T4, and several other hormones, producing false results. Since bloodwork is an important monitoring tool on any AOD-9604 protocol, and since high-dose biotin is commonly sold in hair and skin products at amounts that can interfere, this interaction is worth knowing. Stop high-dose biotin at least 48 hours before any blood draw.

Corticosteroids

Oral or injected corticosteroids, including prednisone and dexamethasone, actively promote fat accumulation, particularly in visceral depots, and reduce insulin sensitivity. They work directly against AOD-9604's lipolytic effects in the same tissue the peptide is targeting. This is not a safety concern in the way the insulin interaction is, but combining the two makes the fat-loss protocol significantly harder and potentially futile. Anyone on corticosteroids should address that before expecting meaningful results from a lipolytic compound.

Alcohol

Alcohol promotes fat synthesis and impairs fat oxidation at the metabolic level, directly opposing both the lipolytic signal AOD-9604 produces and the downstream fat-burning the stack is designed to support. Separating alcohol consumption from the injection by several hours and keeping total intake low during an AOD-9604 cycle is a practical consideration rather than an absolute prohibition, but it is worth being deliberate about if results matter.

Frequently Asked Questions

How much of each supplement should I take with AOD-9604?

There are no dose numbers on this page, and that is intentional. The right amount of protein, creatine, magnesium, or any other supplement on this list depends on your body weight, your current bloodwork, your training volume, your dietary baseline, and the specific AOD-9604 protocol you are running. MyPeptidePal builds a personalized supplement plan from exactly those inputs, so what you get is calibrated to your situation rather than an average that fits almost no one specifically.

Which blood markers are worth monitoring on an AOD-9604 protocol?

AOD-9604 itself leaves remarkably little mark on standard bloodwork. It does not raise IGF-1, does not affect fasting glucose, and does not alter liver enzymes or blood counts in clinical trials. The markers worth watching are the ones the protocol creates indirectly: RBC magnesium and 25-hydroxyvitamin D if you are supplementing those nutrients and want to confirm your status is actually shifting, serum albumin as an early signal that protein intake is falling short of what lean mass preservation requires, and serum triglycerides if you want to see how the increased lipid mobilization is being handled. If you are taking creatine, tell your clinician before any creatinine result is interpreted, because creatine supplementation raises creatinine non-pathologically and can be misread as a kidney concern.

Does AOD-9604 raise IGF-1, and does that change which supplements I need?

No, it does not raise IGF-1. This is one of the compound's defining features and it genuinely changes the supplement context relative to GH secretagogue protocols. Full-length hGH and the secretagogues that stimulate GH release all produce IGF-1 elevation, which carries its own nutritional and metabolic implications. AOD-9604 was specifically engineered to preserve the lipolytic fragment of the growth hormone molecule while eliminating the receptor-binding domains responsible for IGF-1 elevation. The supplement list here reflects a pure lipolytic context, not a GH axis context, and that is a meaningful difference.

Do I need to time these supplements around the fasted injection?

AOD-9604 is dosed fasted, and that timing matters mechanically because insulin opposes the enzyme the peptide activates. Most supplements can be taken separately without disrupting the protocol. A practical approach is to inject in the morning fasted and wait 30 to 60 minutes before eating or taking any supplement that pairs with food. Green tea extract and caffeine can be taken in the same fasted window as the injection without conflict. Protein, creatine, and the fat-soluble supplements like vitamin D3 and omega-3 fatty acids are naturally taken with meals, which places them after the fasted window anyway.

Can I just eat enough protein and skip the rest of the stack?

Protein is the most important single item on this list. If the entire stack came down to one thing, that would be it. AOD-9604 mobilizes fat and does nothing for muscle, and adequate protein is what fills that gap. The rest of the stack addresses the metabolic infrastructure that determines how efficiently the mobilized fatty acids actually get burned: the mitochondrial cofactors, the deficiency corrections, and the synergists that deepen the lipolytic signal. Someone with genuinely good dietary coverage of B vitamins, adequate sun exposure for vitamin D, and no magnesium shortfall will get less from those items than someone who is deficient in one or more of them. The honest answer is that food quality first is the right principle, and the supplements here address the gaps that a caloric-deficit fat-loss protocol commonly creates in practice.

This content is for informational and educational purposes only. It does not constitute medical advice, diagnosis, or treatment recommendations. MyPeptidePal is not a medical provider. Always consult a qualified healthcare professional before starting, modifying, or stopping any health protocol, supplement regimen, or therapeutic intervention.

Sources

The information in this guide is drawn from the MyPeptidePal knowledge base, which brings together published research, clinical data, and documented real-world use of AOD-9604 and the nutrients that support it in one place.